Apriem Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,699
| Closed | -$346K | – | 143 |
|
|
2022
Q2 | $346K | Sell |
1,699
-408
| -19% | -$83.4K | 0.06% | 107 |
|
|
2022
Q1 | $444K | Sell |
2,107
-822
| -28% | -$179K | 0.07% | 101 |
|
|
2021
Q4 | $703K | Sell |
2,929
-33
| -1% | -$8.48K | 0.1% | 75 |
|
|
2021
Q3 | $838K | Sell |
2,962
-21,791
| -88% | -$7.14M | 0.12% | 71 |
|
|
2021
Q2 | $8.57M | Sell |
24,753
-36,409
| -60% | -$11M | 1.28% | 23 |
|
|
2021
Q1 | $17.1M | Buy |
61,162
+8,172
| +15% | +$2.2M | 2.65% | 12 |
|
|
2020
Q4 | $13M | Sell |
52,990
-3,297
| -6% | -$851K | 2.31% | 16 |
|
|
2020
Q3 | $16M | Buy |
56,287
+791
| +1% | +$221K | 2.93% | 9 |
|
|
2020
Q2 | $14.8M | Buy |
55,496
+2,274
| +4% | +$684K | 3.05% | 8 |
|
|
2020
Q1 | $16.8M | Buy |
53,222
+106
| +0.2% | +$32.2K | 4.08% | 4 |
|
|
2019
Q4 | $15.8M | Buy |
53,116
+3,233
| +6% | +$897K | 3.02% | 5 |
|
|
2019
Q3 | $11.6M | Buy |
49,883
+47,363
| +1,879% | +$11M | 2.57% | 7 |
|
|
2019
Q2 | $589K | Buy |
+2,520
| New | +$582K | 0.18% | 74 |
|
|
2018
Q3 | – | Sell |
-42
| Closed | -$12K | – | 169 |
|
|
2018
Q2 | $12K | Buy |
+42
| New | +$11.8K | ﹤0.01% | 398 |
|
|
2017
Q2 | – | Sell |
-42
| Closed | -$11K | – | 182 |
|
|
2017
Q1 | $11K | Hold |
42
| – | – | ﹤0.01% | 407 |
|
|
2016
Q4 | $12K | Buy |
42
+17
| +68% | +$5.04K | ﹤0.01% | 422 |
|
|
2016
Q3 | $8K | Sell |
25
-156
| -86% | -$46.2K | ﹤0.01% | 418 |
|
|
2016
Q2 | $44K | Buy |
181
+6
| +3% | +$1.58K | 0.01% | 240 |
|
|
2016
Q1 | $46K | Hold |
175
| – | – | 0.02% | 211 |
|
|
2015
Q4 | $54K | Hold |
175
| – | – | 0.02% | 195 |
|
|
2015
Q3 | $51K | Buy |
175
+150
| +600% | +$49.5K | 0.02% | 200 |
|
|
2015
Q2 | $10K | Hold |
25
| – | – | ﹤0.01% | 412 |
|
|
2015
Q1 | $11K | Hold |
25
| – | – | ﹤0.01% | 399 |
|
|
2014
Q4 | $8K | Buy |
+25
| New | +$8.09K | ﹤0.01% | 387 |
|
Other funds holding BIIB
